Compare SMTI & BZAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SMTI | BZAI |
|---|---|---|
| Founded | 1982 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 313.5M | 268.9M |
| IPO Year | 2008 | 2021 |
| Metric | SMTI | BZAI |
|---|---|---|
| Price | $34.00 | $0.52 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | ★ $34.00 | $4.67 |
| AVG Volume (30 Days) | 399.7K | ★ 5.7M |
| Earning Date | 05-12-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 43.43 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $15,586,976.00 | N/A |
| Revenue This Year | $17.31 | $239.02 |
| Revenue Next Year | $12.48 | $45.85 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 32.47 | N/A |
| 52 Week Low | $16.05 | $0.54 |
| 52 Week High | $35.70 | $6.76 |
| Indicator | SMTI | BZAI |
|---|---|---|
| Relative Strength Index (RSI) | 80.05 | 28.00 |
| Support Level | $33.68 | N/A |
| Resistance Level | $34.33 | $1.64 |
| Average True Range (ATR) | 0.61 | 0.11 |
| MACD | -0.06 | -0.02 |
| Stochastic Oscillator | 96.27 | 2.70 |
Sanara MedTech Inc is a medical technology company focused on developing and commercializing technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market. It markets and sells soft tissue repair and bone fusion products for use in operating rooms and sterile environments. Its soft tissue repair products include CellerateRX Surgical Powder, a hydrolyzed collagen used in management of surgical wounds, and BIASURGE Surgical Solution, a sterile no-rinse solution for wound irrigation, while its bone fusion products include BiFORM Bioactive Moldable Matrix, an osteoconductive implant that supports bone growth, and ALLOCYTE Plus Viable Bone Matrix, a human allograft cellular bone matrix containing bone-derived progenitor cells and conformable bone fibers.
Blaize Holdings Inc provides transformative artificial intelligence (AI)-enabled edge computing solutions comprised of both its proprietary hardware and software, and third-party hardware solutions. Its portfolio includes programmable AI processors in various form factors, which can be deployed across sectors such as smart cities, defense, retail, and enterprise markets. The company operates as a single operating and reportable segment. The majority of the company's revenue is derived from Hardware revenue, which includes the sale of its semiconductor products and/or third-party hardware products that support semiconductor products through various supply agreements. Geographically, it generates the maximum revenue from China.